tradingkey.logo

GeneDx Holdings Corp

WGS
View Detailed Chart

123.110USD

+6.700+5.76%
Close 08/13, 16:00ETQuotes delayed by 15 min
3.53BMarket Cap
LossP/E TTM

GeneDx Holdings Corp

123.110

+6.700+5.76%
Intraday
1m
30m
1h
D
W
M
D

Today

+5.76%

5 Days

+16.31%

1 Month

+49.12%

6 Months

+57.83%

Year to Date

+60.17%

1 Year

+260.50%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 7 analysts
BUY
Current Rating
115.286
Target Price
-0.97%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

69
Total
7
Median
8
Average
Company name
Ratings
Analysts
GeneDx Holdings Corp
WGS
7
CVS Health Corp
CVS
29
HCA Healthcare Inc
HCA
27
Teladoc Health Inc
TDOC
27
Tenet Healthcare Corp
THC
24
Natera Inc
NTRA
22
1
2
3
...
14

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Buy
Sell(1)
Neutral(0)
Buy(9)
Indicators
Sell(1)
Neutral(0)
Buy(3)
Indicators
Value
Direction
MACD(12,26,9)
4.453
Buy
RSI(14)
79.407
Buy
STOCH(KDJ)(9,3,3)
97.066
Overbought
ATR(14)
7.371
High Vlolatility
CCI(14)
161.190
Buy
Williams %R
0.249
Overbought
TRIX(12,20)
1.365
Sell
StochRSI(14)
100.000
Overbought
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
112.228
Buy
MA10
108.554
Buy
MA20
96.375
Buy
MA50
86.012
Buy
MA100
84.228
Buy
MA200
82.439
Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

GeneDx Holdings Corp. is a genomics company. The Company is focused on delivering personalized and actionable health insights to inform diagnosis, direct treatment and improve drug discovery. The Company's segments are GeneDx inclusive of Legacy GeneDx and Legacy Sema4. The GeneDx segment primarily provides pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing and, to a lesser extent, data and information services. GeneDx utilizes an integrated portfolio of laboratory processes, software tools, and informatics capabilities to process deoxyribonucleic acid (DNA)-containing samples, analyze information about patient-specific genetic variation and generate test reports for clinicians and their patients. GeneDx provides a variety of genetic diagnostic tests, screening solutions, and information. The Legacy Sema4 diagnostics segment provides reproductive and women's health and somatic oncology diagnostic testing and screening products.
Ticker SymbolWGS
CompanyGeneDx Holdings Corp
CEOMs. Katherine A. Stueland
Websitehttps://sema4.com/
KeyAI